Loss Ratio

In insurance, the loss ratio is the ratio of the total amount of claims paid out by an insurance company to the total amount of premiums collected. It is a measure of the profitability of an insurance company's underwriting activities.

The loss ratio is calculated by dividing the total amount of claims paid out by an insurance company over a given period of time by the total amount of premiums collected over the same period of time. For example, if an insurance company collects $1 million in premiums and pays out $700,000 in claims, its loss ratio for that period would be 70%.

The key features of loss ratio include:

• It is a measure of an insurance company's profitability and the effectiveness of its underwriting process.

• A high loss ratio indicates that an insurance company is paying out more in claims than it is collecting in premiums, which could result in financial difficulties for the company.

• Insurance companies typically aim for a loss ratio of around 60-70%, although this can vary depending on the type of insurance and the company's business strategy.

• Loss ratios can vary widely between different types of insurance. For example, property insurance typically has a lower loss ratio than health insurance, due to the lower frequency and severity of claims in property insurance.

• Loss ratios can be influenced by a variety of factors, including the underwriting standards of the insurance company, the level of competition in the market, and changes in the regulatory environment.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.